Delivery Order SPE2DB20D2104-SPE2DB25FMSMX
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on September 5, 2025. This competitively awarded, non-set-aside contract has a ceiling value of $3,069.11 and is structured as a firm fixed price delivery order with an ultimate completion date of September 8, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $5,652.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors with an ultimate completion date of September 8, 2025. This non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's substantial Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $13,172.65 delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pen injectors with a completion date of April 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Mounjaro 2.5 mg/0.5 ml pen injectors, with a ceiling value of $8,139.32. This firm fixed-price delivery order represents a non-competitive procurement vehicle, reflecting AmerisourceBergen's established position as a critical pharmaceutical supplier to federal healthcare systems. The contract is set to conclude on June 20, 2025, with fulfillment occurring at...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency on May 7, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors valued at $27,363.70, with completion scheduled for May 8, 2025. The order represents a firm fixed-price, competitively awarded delivery against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. Performance will be...
- The Defense Logistics Agency has awarded a delivery order valued at $1,452.55 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors. The contract, awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $5,067.81 delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pen injectors on July 23, 2025, with completion scheduled for July 24, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement extending through December 2026. The product will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mounjaro 2.5 mg/0.5 mL pen injectors valued at $7,226.22 with a firm fixed price structure. The contract, awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's existing indefinite delivery contract vehicle. Performance will occur at the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $4,212.77 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors, with an ultimate completion date of August 11, 2025. This competitive award, issued on a firm fixed price basis, represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026). The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pen injectors, valued at $22,549.80 under a firm fixed-price contract type. The award, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a non-competitive set-aside delivery order. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMSMXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors valued at $4,531.80. This firm fixed-price delivery order, issued on June 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract involves no set-aside designation and was competitively awarded. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with a completion date of June 5, 2025. This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical vendor within the Defense Logistics Agency's Medical Supply Chain. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies a comprehensive range of medications and medical devices to support military and veteran healthcare systems. Mounjaro, a diabetes medication, aligns with AmerisourceBergen's extensive portfolio of specialty pharmaceutical products delivered through multiple delivery orders under its primary indefinite delivery vehicle with DLA Troop Support Medical, enabling flexible fulfillment of federal healthcare requirements across various therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 6/4/25 |